Linde (LIN) Signs Chip Supply Deals, Is The Stock Fully Priced?
Linde (LIN) has signed multiyear gas supply agreements tied to advanced semiconductor fabrication, drawing fresh attention to how this industrial gases giant is positioning around chip manufacturing demand.
The new semiconductor contracts arrive as Linde’s share price trades around US$492.70. The 30-day share price return is 6.42%, building on a 14.82% year-to-date gain, even though the 90-day share price performance declined 4% and the 1-year total shareholder return sits at 12.41%.
Scan how Linde’s chip-related contracts compare with those of other potential beneficiaries of semiconductor demand with a curated list of 92 AI infrastructure stocks.
Bulls see Linde’s chip contracts and US$227.3b market value as support for a premium multiple. Bears point to a 4% 90-day share price decline. Which case does the current valuation lean toward?
Most Popular Narrative: 9.5% Undervalued
Linde’s most followed valuation story places fair value at $544.40, above the recent $492.70 close. This helps explain why semiconductor and helium projects are drawing so much attention from long term holders. That gap between price and narrative fair value sets the stage for how investors frame the chip supply deals just announced.
Linde's position supplying ultra high purity gases to large advanced node semiconductor complexes in Arizona and Taiwan, backed by about US$1.8b of recent investment and strong AI related electronics demand, points to rising project start ups. These can convert the current backlog into higher sale of gas revenue and earnings over time.
See why 117 investors see Linde as 9% undervalued.
Result: Fair Value of $544.40 (UNDERVALUED)
Still, the narrative can break if Europe sees deeper industrial shutdowns, or if the U.S. homecare drag keeps Linde’s Americas margins under pressure.
Find out about the key risks to this Linde narrative.
Another View: What Linde’s P/E Is Really Pricing In
The first story paints Linde as about 9.5% below a US$544.40 fair value. A second lens is simple. The stock trades on a 31.4x P/E, while the fair ratio is 23.2x and the wider US Chemicals industry is at 21.3x. That gap raises a blunt question: Is the chip and helium narrative strong enough to keep this premium intact?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed signals on Linde and chip demand can pull you in opposite directions, so move quickly to test the numbers yourself and decide where you land by reviewing the 2 key rewards and 1 important warning sign.
Looking for more Linde investment ideas?
If Linde has your attention but you want more context, broaden your opportunity set now with a few focused lists that surface very different kinds of stocks.
- Target potential upside by scanning a curated pool of companies that combine strong cash flows with attractive pricing through the 32 high quality undervalued stocks.
- Build a steadier income stream by reviewing businesses that offer robust yields and payout profiles inside the 7 dividend fortresses.
- Prioritise resilience by focusing on sturdier balance sheets and cleaner fundamentals using the list of solid balance sheet and fundamentals (25 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com